Advanced in Ectropion

Simonetta Morselli

Bassano Del Grappa, IT 
Advanced in Ectropion
Bassano Del Grappa, IT 
OverviewLocationsClinical Research

Overview

Simonetta Morselli practices in Bassano Del Grappa, Italy. Ms. Morselli is rated as an Advanced expert by MediFind in the treatment of Ectropion. Her top areas of expertise are Cataract, Ectropion, Glaucoma, Ocular Hypertension (OHT), and Cataract Removal.

Her clinical research consists of co-authoring 12 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Ectropion.

Gender
Female

Locations

Bassano Del Grappa, Italy
Other Locations
Vicenza, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Evaluation of Long-Term Clinical Acceptability and Satisfaction With the IC-8 Intraocular Lens
Evaluation of Long-Term Clinical Acceptability and Satisfaction With the IC-8 Intraocular Lens
Enrollment Status: Completed
Publish Date: May 13, 2022
Intervention Type: Device
An International, Multicenter, Randomized, Blinded-assessor, Parallel-group Clinical Study Comparing Eye Drops of Combined LEvofloxAcin + DExamethasone foR 7 Days Followed by Dexamethasone Alone for an Additional 7 Days vs. Tobramycin + Dexamethasone for 14 Days for the Prevention and Treatment of Inflammation and Prevention of Infection Associated With Cataract Surgery in Adults - LEADER 7
An International, Multicenter, Randomized, Blinded-assessor, Parallel-group Clinical Study Comparing Eye Drops of Combined LEvofloxAcin + DExamethasone foR 7 Days Followed by Dexamethasone Alone for an Additional 7 Days vs. Tobramycin + Dexamethasone for 14 Days for the Prevention and Treatment of Inflammation and Prevention of Infection Associated With Cataract Surgery in Adults - LEADER 7
Enrollment Status: Completed
Publish Date: August 18, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

12 Total Publications

Theoretic scientific rationale of double XEN 45 Gel Stent implant in severe glaucomatous ocular hypertension.
Theoretic scientific rationale of double XEN 45 Gel Stent implant in severe glaucomatous ocular hypertension.
Journal: International ophthalmology
Published: February 04, 2022

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Morselli's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile